ADVFN US – Market Content Editor
-
Boston Scientific Tops Q4 Forecasts, Shares Slip Modestly
Boston Scientific Corporation (NYSE:BSX) delivered stronger-than-expected results for the fourth quarter of 2025 on Wednesday, with both earnings and revenue coming in ahead of Wall Street estimates, although the stock edged lower in premarket trading. Shares of the medical device maker were down 0.47% ahead of the open following the earnings release. Adjusted earnings per…
-
Oaktree Specialty Lending Falls Short of Q1 Earnings Forecasts
Oaktree Specialty Lending Corporation (NASDAQ:OCSL) reported fiscal first-quarter 2026 results that missed market expectations, with earnings pressured by sizable investment losses despite relatively stable operating income. The business development company posted earnings per share of $0.06, well below the consensus estimate of $0.38. Quarterly revenue totaled $75.1 million, slightly under analysts’ forecast of $75.27 million.…
-
American Airlines CEO Isom Faces Growing Pilot Backlash After Underwhelming Performance
American Airlines Group Inc. (NASDAQ:AAL) CEO Robert Isom is coming under increasing scrutiny from the carrier’s pilots, who argue that his leadership has left the airline lagging behind rivals Delta Air Lines Inc. (NYSE:DAL) and United Airlines Holdings Inc. (NASDAQ:UAL) in terms of profitability. The Allied Pilots Association (APA), which represents roughly 16,000 pilots at…
-
Stanley Black & Decker Beats Q4 Profit Estimates Despite Revenue Miss
Stanley Black & Decker (NYSE:SWK) reported fourth-quarter adjusted earnings that came in ahead of Wall Street forecasts on Wednesday, even as revenue failed to meet expectations amid weaker retail demand in North America. Shares of the tools and outdoor products maker fell about 1.3% following the results. The company posted adjusted earnings per share of…
-
Bunge Beats Q4 Estimates but Strikes Cautious Tone With 2026 Guidance
Bunge Global SA (NYSE:BG) delivered stronger-than-expected fourth-quarter results on Wednesday, although the agribusiness group offered a restrained earnings outlook for 2026 that came in below market expectations. Shares were little changed in after-hours trading following the release. For the quarter, Bunge reported adjusted earnings of $1.99 per share, topping the analyst consensus of $1.89. Revenue…
-
Silgan Holdings Tops Q4 Forecasts as Pet Food Packaging Drives Growth
Silgan Holdings Inc. (NYSE:SLGN) posted better-than-expected fourth-quarter results on Wednesday, helped by solid demand in pet food packaging, particularly within its metal containers business. The company reported adjusted earnings per share of $0.67 for the quarter, beating analysts’ expectations of $0.64. Revenue came in at $1.47 billion, narrowly ahead of the $1.46 billion consensus forecast.…
-
Chipotle Shares Slide After Company Signals Flat Comparable Sales in 2026
Shares of Chipotle Mexican Grill Inc (NYSE:CMG) fell sharply in U.S. premarket trading on Wednesday after the restaurant group delivered better-than-expected quarterly results but issued a cautious outlook for 2026, projecting flat comparable sales that fell short of Wall Street forecasts. The burrito chain reported fourth-quarter earnings of $0.25 per share, beating analysts’ estimates by…
-
Super Micro Computer Jumps as AI-Led Demand Fuels Huge Revenue Beat
Shares of Super Micro Computer Inc (NASDAQ:SMCI) surged in U.S. premarket trading after the AI-focused server maker reported fiscal second-quarter results that smashed expectations and prompted an upgrade to its full-year outlook. For the quarter ended December 31, the company delivered adjusted earnings per share of $0.69, exceeding the consensus estimate of $0.49 by more…
-
Amgen Tops Forecasts, Delivers Robust 2026 Outlook as Shares Edge Higher
Amgen (NASDAQ:AMGN) reported stronger-than-expected fourth-quarter results, posting solid revenue growth and upbeat guidance for 2026, which helped lift its shares slightly in premarket trading on Wednesday. The biotech group said quarterly revenue rose 9% year over year to $9.9 billion, beating the market consensus of $9.46 billion. Adjusted earnings per share came in at $5.29,…
-
Novo Nordisk Shares Slide After Company Flags Weaker 2026 Sales Outlook
Shares in Novo Nordisk A/S (NYSE:NVO) fell sharply after the maker of Wegovy reported fourth-quarter results and issued a downbeat sales outlook for 2026, catching investors off guard. The company said it expects adjusted sales growth in 2026—excluding revenue linked to the reversal of 340B provisions—to range between -5% and -13% at constant exchange rates.…